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Background: The purpose of this study was to report the case of a patient with bilateral panuveitis who was found
to have a rarely reported intraocular fungus, Aspergillus conicus. A 40-year-old man presented with gradual vision
loss in both eyes. He had bilateral anterior uveitis, granulomatous vitritis with a preretinal granuloma in the right
eye, and nongranulomatous vitritis with two quadrants of chorioretinal scarring in the left.
Findings: Serological testing revealed a new diagnosis of human immunodeficiency virus as well as positive rapid
plasma reagin and fluorescent treponemal antibody. Polymerase chain reaction (PCR) testing of the aqueous humor
from the right eye identified A. conicus. Due to the indolent course of the endogenous fungal infection, the patient
was treated with prednisolone acetate 1% eye drops, oral voriconazole, and highly active antiretroviral therapy.
More than 1 year later, his vision remained 20/20 in both eyes without any episodes of recurrent inflammation.
Conclusions: PCR testing helped identify a rare intraocular infection in an immunocompromised patient. In this
case, A. conicus behaved less aggressively than other species of Aspergillus implicated in intraocular infection.
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Introduction
Aspergillus is the second most common cause of endoge-
nous fungal endophthalmitis after Candida and is more
likely to occur in immunocompromised patients due to
HIV, malignancy, diabetes mellitus, or immunosuppressive
medications [1]. Other associations include intravenous
drug use, solid organ transplantation, lung disease, and
renal insufficiency; however, Aspergillus endophthalmitis
may occur in immunocompetent individuals with no
known risk factors [2]. In general, the prognosis is poor
for preservation of vision and even the eye itself [3].
Disseminated aspergillosis can be fatal, but isolated
ophthalmic disease is not uncommon, especially among
immunocompetent patients. We describe a patient who
presented with bilateral panuveitis and was subse-
quently diagnosed with HIV. Polymerase chain reaction
(PCR) testing of the aqueous humor (AH) identified* Correspondence: senh@nei.nih.gov
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in any medium, provided the original work is pAspergillus conicus, a species rarely associated with
intraocular infection.
Case report
A 40-year-old white man was referred to our uveitis
clinic with several weeks of painless, gradual vision loss
in both eyes (OU) and several months of low-grade
fevers and weight loss. Five years prior to presentation,
he had been diagnosed with uveitis and syphilis (rapid
plasma reagin (RPR) 1:1,024). After treatment with pred-
nisolone acetate 1% eye drops and three intramuscular
penicillin injections, his vision returned to normal, but
he did not return for follow-up. Just prior to referral to
our clinic, his vision was 20/50 in the right eye (OD)
and 20/60 in the left (OS); prednisolone acetate 1%
drops were started OU.
On examination, visual acuity was 20/20 OD and 20/32
OS. There were trace cells in both anterior chambers.
Both eyes also had 1+ vitreous cell and trace haze (based
on the National Eye Institute vitreous grading scale) [4],
but the OD vitreous cell had distinct granulomatous-
appearing clumps. In the nasal periphery OD, there was an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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creamy, white, deep retinal lesions and intraretinal
hemorrhages (Figure 1a,c). The superior and inferior nasal
retina OS had large, wedge-shaped quadrants of
pigmented chorioretinal atrophy and scarring (Figure 1b).
Fluorescein angiography (FA) showed hyperfluorescence
of the preretinal granuloma and the surrounding deep
retinal lesions OD (Figure 1d) and staining of the
chorioretinal scars, focal vasculitis, and minimal perifoveal
leakage OS.
On physical examination, he had severe fingernail
onychomycosis, oral thrush, and multiple raised, red cu-
taneous lesions on his extremities and trunk. Further
history revealed a chronic cough for several years; he
quit smoking methamphetamines 6 years earlier. He also
had a history of same-sex partners. Lab testing revealed
a reactive HIV1/2 antibody (confirmed by Western blot)
and a CD4 count of 158 cells/μL. RPR was reactive (1:2)
with a positive syphilis IgG and reactive FTA-ABS. The
following were negative: QuantiFERON-TB, Toxoplasma
IgG, and Toxocara titer. PCR of AH OD was negative
for CMV, VZV, HSV, and toxoplasma and positive for a
panfungal amplicon using the internal transcribed
spacer, a 500-bp sequence, and a highly variable region
of the fungal ribosomal DNA as the primers. Sequencing
identified A. conicus. There was no growth in fungal
cultures of AH and peripheral blood.
A chest CT showed diffuse bilateral interstitial
opacities and nodular densities, and consolidation in theFigure 1 Color montages upon presentation and FA images upon pre
left (b) eyes upon presentation to our clinic. Detail of the color (c) and FA
to emanate from a retinal vessel with reactive, adherent vitreous. FA (e) of
intravenous penicillin.dependent lower lobes. A bronchoalveolar lavage speci-
men was negative for the Fungitell assay, Aspergillus anti-
gen, Pneumocystis, acid-fast stain, and mycobacterial and
Nocardia cultures. Biopsy of a skin lesion was consistent
with Kaposi's sarcoma. A brain MRI was unremarkable.
Since the patient's vision and clinical exam remained
stable, prednisolone acetate 1% eye drops were continued
in conjunction with continuous intravenous penicillin
(2-week course), oral voriconazole 200 mg twice daily,
and highly active antiretroviral therapy (HAART).
Seven weeks later, the lesion in the right eye appeared
less active (Figure 1e). By 4 months, the panuveitis was
quiescent with visual acuity 20/20 OU. The presumed
diagnoses were endogenous A. conicus endophthalmitis
OD and panuveitis OU possibly due to syphilis (reinfec-
tion or insufficient treatment in 2005). The chorioretinal
scars OS remained inactive and were likely related to the
previous syphilis-related uveitis in 2005. He remained
quiet without recurrent uveitis throughout a 1-year course
of voriconazole as well as 2 months after stopping the
antifungal medication.
The patient signed a research protocol consent (approved
by the NIH IRB in accordance with the Helsinki Decla-
ration) which states that data collected from exam visits
might be published.
Discussion and conclusion
Aspergillus has a ubiquitous presence in the environ-
ment as a saprophytic mold isolated from soil andsentation and after treatment. Color montages of the right (a) and
(d) images of the right eye on presentation: The fluffy lesion appeared
the right eye 6 weeks after starting HAART, voriconazole, and
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are the most common species implicated in intraocular
infection. Other species detected in ophthalmic disease
include A. niger, A. terreus, A. ustus, A. glaucus, and A.
versicolor [5-8]. The species in our case, A. conicus, is
rarely mentioned in the medical literature, and the only
previous report of ophthalmic involvement was from a
patient with postsurgical endophthalmitis [9]. A. conicus
has also been isolated from the respiratory tracts of
healthy people in Japan, Taiwan, and South Korea [10].
Interestingly, our patient did have a history of travel to
Korea and Japan where he might have come into contact
with A. conicus.
Treatment for Aspergillus endophthalmitis classically
involves intravitreal and/or systemic amphotericin B,
although the intraocular form has been associated with
retinal toxicity [11]. Intravitreal dexamethasone is some-
times administered in conjunction with the intravitreal
antifungal medication to reduce intraocular inflamma-
tion although the efficacy has not been tested in con-
trolled, masked studies [1,5,12,13]. Pars plana vitrectomy
is often performed for diagnostic and therapeutic
purposes, especially when the diagnosis is unknown or
the vision is severely compromised. Several species can
be highly resistant to amphotericin B, and side effects
often limit its systemic use. Alternative systemic
antifungals including caspofungin and voriconazole can
be effective as well, although vitrectomy may still be
necessary with extensive, sight-threatening intraocular
involvement. Voriconazole has good intraocular pene-
tration allowing systemic treatment alone in selected
cases such as ours; when used intravitreally, it may be
safer than amphotericin B [11].
In addition to the identification of a rare Aspergillus
species, A. conicus, our case differs from others in terms
of presentation and outcome. Our patient had gradual,
painless vision loss without conjunctival hyperemia or
severe anterior chamber inflammation. The disease
course was indolent, and systemic treatment alone
resulted in good visual acuity that remained stable with-
out recurrent inflammation more than 1 year later. In
most cases, Aspergillus endophthalmitis requires sys-
temic and intravitreal antifungal treatment as well as
vitrectomy, and the visual outcome is poor; however, our
patient had nonmacular threatening disease and did not
progress on systemic therapy, so surgery and intravitreal
antifungals were unnecessary. No other focus of A.
conicus infection was detected, although the lungs were
the most likely entry point. It is possible that A. conicus
is not as aggressive as other species implicated in
Aspergillus endophthalmitis, although the very small
number of reported infections does not allow a definitive
conclusion. We do not routinely perform repetitive AH
sampling on an eye with very good visual acuity if thereis an appropriate response to treatment and quiescent
inflammation; therefore, we cannot provide direct proof
of treatment success in this case.
PCR played an important role in the identification of
the presumed causative organism in this case and
allowed targeted antifungal therapy rather than just
antibiotics for ocular syphilis and HAART for HIV. As
the yield from ocular fluid cultures is frequently poor, it
is possible that A. conicus has been responsible for
endophthalmitis in cases in which no organism was
cultured or the species could not be identified. Many
studies have demonstrated the utility of PCR especially
since multiplex testing can be performed on a very small
volume of fluid [14,15]. Due to the sterile intraocular en-
vironment, ocular fluids can be ideal for PCR examination,
although environmental contamination by commensal
microorganisms is still a potential confounding factor.
In summary, we describe a patient with bilateral
panuveitis who was diagnosed with an unusual fungal
endophthalmitis and an underlying immunodeficiency
due to HIV. Our case emphasizes the importance of a
detailed review of systems which may reveal related in-
fectious or inflammatory issues with potentially serious
systemic consequences.
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